Authors: Hatse, S Princen, K Gerlach, LO Bridger, G Henson, G De Clercq, E Schwartz, TW Schols, D

Citation: S. Hatse et al., Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100, MOLEC PHARM, 60(1), 2001, pp. 164-173

Authors: Blanco, J Barretina, J Henson, G Bridger, G De Clercq, E Clotet, B Este, JA

Citation: J. Blanco et al., The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis, ANTIM AG CH, 44(1), 2000, pp. 51-56

Authors: Van Gelder, J Witvrouw, M Pannecouque, C Henson, G Bridger, G Naesens, L De Clercq, E Annaert, P Shafiee, M Van den Mooter, G Kinget, R Augustijns, P

Citation: J. Van Gelder et al., Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA, INT J PHARM, 186(2), 1999, pp. 127-136

Authors: Este, JA Cabrera, C De Clercq, E Struyf, S Van Damme, J Bridger, G Skerlj, RT Abrams, MJ Henson, G Gutierrez, A Clotet, B Schols, D

Citation: Ja. Este et al., Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor, MOLEC PHARM, 55(1), 1999, pp. 67-73

Authors: Egberink, HF De Clercq, E Van Vliet, ALW Balzarini, J Bridger, GJ Henson, G Horzinek, MC Schols, D

Citation: Hf. Egberink et al., Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication, J VIROLOGY, 73(8), 1999, pp. 6346-6352

Authors: Este, JA Cabrera, C Blanco, J Gutierrez, A Bridger, G Henson, G Clotet, B Schols, D De Clercq, E

Citation: Ja. Este et al., Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4, J VIROLOGY, 73(7), 1999, pp. 5577-5585